Have a feature idea you'd love to see implemented?
Let us know!
IDXX Idexx Laboratories Inc
Price (delayed)
$452.27
Market cap
$37.22B
P/E Ratio
44.38
Dividend/share
N/A
EPS
$10.19
Enterprise value
$37.87B
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
The company's equity rose by 44% YoY
IDXX's price to earnings (P/E) is 23% lower than its 5-year quarterly average of 57.5 and 11% lower than its last 4 quarters average of 49.6
The quick ratio has increased by 25% YoY but it has decreased by 12% QoQ
The company's EPS rose by 7% YoY but it fell by 2.3% QoQ
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
82.31M
Market cap
$37.22B
Enterprise value
$37.87B
Price to earnings (P/E)
44.38
Price to book (P/B)
23.64
Price to sales (P/S)
9.87
EV/EBIT
34.55
EV/EBITDA
31.12
EV/Sales
10.01
Revenue
$3.78B
EBIT
$1.1B
EBITDA
$1.22B
Free cash flow
$838.95M
Per share
Balance sheet
Liquidity
EPS
$10.19
Free cash flow per share
$10.15
Book value per share
$19.13
Revenue per share
$45.8
TBVPS
$35.05
Total assets
$3.41B
Total liabilities
$1.83B
Debt
$1.05B
Equity
$1.58B
Working capital
$411.91M
Debt to equity
0.66
Current ratio
1.37
Quick ratio
0.84
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
32.2%
Gross margin
60.4%
Net margin
22.3%
Operating margin
28.6%
Return on assets
25.8%
Return on equity
57%
Return on invested capital
44.5%
Return on capital employed
47.7%
Return on sales
29%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
-1.23%
1 week
-1.68%
1 month
-10.69%
1 year
4.99%
YTD
-18.52%
QTD
-10.48%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.78B
Gross profit
$2.29B
Operating income
$1.08B
Net income
$845.63M
Gross margin
60.4%
Net margin
22.3%
IDXX's revenue is up by 8% year-on-year
The gross profit has increased by 8% YoY and by 2.1% QoQ
The company's net income rose by 7% YoY but it fell by 2.4% QoQ
IDXX's operating margin is down by 4.7% QoQ and by 4% YoY
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
44.38
P/B
23.64
P/S
9.87
EV/EBIT
34.55
EV/EBITDA
31.12
EV/Sales
10.01
IDXX's price to earnings (P/E) is 23% lower than its 5-year quarterly average of 57.5 and 11% lower than its last 4 quarters average of 49.6
The company's EPS rose by 7% YoY but it fell by 2.3% QoQ
The price to book (P/B) is 65% less than the 5-year quarterly average of 68.2 and 16% less than the last 4 quarters average of 28.3
The company's equity rose by 44% YoY
The P/S is 20% below the 5-year quarterly average of 12.4 and 13% below the last 4 quarters average of 11.4
IDXX's revenue is up by 8% year-on-year
Efficiency
How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 46% YoY and by 11% QoQ
The return on assets has declined by 10% year-on-year and by 7% since the previous quarter
The company's return on sales fell by 4% QoQ and by 3% YoY
Idexx Laboratories's return on invested capital has increased by 3.7% YoY
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 86% higher than its total liabilities
The quick ratio has increased by 25% YoY but it has decreased by 12% QoQ
The company's total assets rose by 19% YoY
The debt is 34% less than the equity
The company's equity rose by 44% YoY
IDXX's debt to equity is down by 37% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.